SCHEDULE: Sapient Capital Discloses 3.9% Stake in Intensity Therapeutics
Beneficial Ownership Report
Sapient Capital LLC has filed an amended Schedule 13G, reporting a beneficial ownership of 3.9% of Intensity Therapeutics, Inc.'s common stock as of June 30, 2025.
Summary
- Sapient Capital LLC reported beneficial ownership of 976,797 shares of Intensity Therapeutics, Inc. common stock.
- This represents 3.9% of the total class of securities.
- Sapient Capital LLC holds shared dispositive power over all 976,797 shares.
- The filing is an Amendment No. 1 to a Schedule 13G.
- Sapient Capital LLC is classified as an Investment Adviser.
Sentiment
Score: 5
Explanation: The document is a factual disclosure of beneficial ownership and does not contain positive or negative operational information, thus a neutral sentiment score is appropriate.
Future Outlook
NA
Industry Context
This filing is a standard disclosure of institutional ownership, common across all industries, and does not provide specific insights into broader industry trends for the pharmaceutical or biotechnology sector beyond the fact that an investment adviser holds a stake in a company within it.
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant institutional ownership stake, which can influence market perception of institutional confidence.
Key Dates
| Date | Description |
|---|---|
| 06/30/2025 | Date of event which requires filing of this statement, indicating the beneficial ownership position. |
| 07/09/2025 | Date the Schedule 13G Amendment No. 1 was signed and filed by Sapient Capital LLC. |
Keywords
Intensity Therapeutics, Sapient Capital, Schedule 13G, Beneficial Ownership, Common Stock, Investment Adviser, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.